& Yue, S
Title : Use of GLP1-RAs in patients with a history of cholelithiasis Author: Sarah Hughes, PharmD Candidate 2024 University of Rhode Island, School of Pharmacy Reviewer: Courtney Cameron, PharmD, BCACP Background Cholelithiasis, also known as gallstones, are hardened collections of bile materials such as cholesterol or bilirubin that collect at the bottom of the gallbladder
In MASH (metabolic dysfunction-associated steatohepatitis, formerly NASH), semaglutide 2.4 mg showed significant resolution of steatohepatitis in a proportion of patients
Its unique properties and benefits make it a valuable ingredient in many different products and treatments
#GLP1 #OralSemaglutide #Obesity #OASIS4 #Rybelsus #Wegovy #NovoNordisk #MetabolicHealth #ClinicalTrials To view or add a comment, sign in Renal failure means the kidneys are unable to filter waste products, balance fluids, and regulate electrolytes effectively